Who
Huda Y. Zoghbi
Director
Company insider
Files Form 4 as: Director, Regeneron Pharmaceuticals.
In numbers
- Trades disclosed
- 93
- Buys
- 0
- Sells
- 11
- Bought
- $0
- Sold
- $13.8M
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 9 Sep 2016
- Last trade
- 10 Aug 2026
- Last filed
- 12 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Aug 2026filed 12 Aug 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Code M | $301K800 at $376.69 | filing |
| 10 Aug 2026filed 12 Aug 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $640K800 at $800.00 | filing |
| 10 Aug 2026filed 12 Aug 2026 | REGN Regeneron Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —800 at $0.00 | filing |
| 10 Aug 2026filed 12 Aug 2026 | REGN Regeneron Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —800 at $0.00 | filing |
| 10 Aug 2026filed 12 Aug 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Code M | $301K800 at $376.69 | filing |
| 10 Aug 2026filed 12 Aug 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $640K800 at $800.00 | filing |
| 19 Feb 2026filed 23 Feb 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Code M | $617K1,638 at $376.69 | filing |
| 19 Feb 2026filed 23 Feb 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $126K160 at $784.45 | filing |
| 19 Feb 2026filed 23 Feb 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $44K56 at $785.61 | filing |
| 19 Feb 2026filed 23 Feb 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $3,1604 at $790.00 | filing |
| 19 Feb 2026filed 23 Feb 2026 | REGN Regeneron Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,638 at $0.00 | filing |
| 19 Feb 2026filed 23 Feb 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $38K49 at $774.68 | filing |
| 19 Feb 2026filed 23 Feb 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $39K50 at $775.50 | filing |
| 19 Feb 2026filed 23 Feb 2026 | REGN Regeneron Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,638 at $0.00 | filing |
| 19 Feb 2026filed 23 Feb 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $41K53 at $778.47 | filing |
| 19 Feb 2026filed 23 Feb 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $162K208 at $779.55 | filing |
| 19 Feb 2026filed 23 Feb 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $258K331 at $780.45 | filing |
| 19 Feb 2026filed 23 Feb 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $163K209 at $781.28 | filing |
| 19 Feb 2026filed 23 Feb 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $233K298 at $782.10 | filing |
| 19 Feb 2026filed 23 Feb 2026 | REGN Regeneron PharmaceuticalsBiotechnology | SEC FORM 4 Code M | $617K1,638 at $376.69 | filing |
News
1,598 Regeneron Pharmaceuticals, Inc. $REGN Shares Sold by Perpetual LtdREGN · dailypolitical.com · 15 Oct 2026Regeneron Pharmaceuticals (NASDAQ:REGN) Stock Price Up 3.6% – Here's What HappenedREGN · dailypolitical.com · 14 Oct 2026
0 headlines in the last 90 days name Huda Y. Zoghbi; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.